Michael J. Smith

Internal Medicine
714 W Hamilton Ave
Eau Claire, WI 54701

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Safety and Immunogenicity of DTaP5-IPV Compared With DTaP5 Plus IPV as the Fifth Dose in Children 4-6 Years of Age.

Safety and Immunogenicity of DTaP5-IPV Compared With DTaP5 Plus IPV as the Fifth Dose in Children 4-6 Years of Age.

Journal: The Pediatric infectious disease journal
Published: November 24, 2016
Showing 1-1 of 1

Last Updated: 09/26/2026